Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

HIV Infection

Free Subscription 21.10.2019 4 AIDS Res Hum Retroviruses 3 Am J Epidemiol 1 Ann Intern Med 3 Antimicrob Agents Chemother 1 BMC Immunol 1 Br J Haematol 12 Clin Infect Dis 6 HIV Med 1 Int J Cancer 6 J Acquir Immune Defic Syndr 3 J Infect Dis 1 J Med Virol 6 J Virol 2 Lancet Glob Health 8 Lancet HIV 1 Lancet Respir Med 1 Nature 13 PLoS One 1 PLoS Pathog 1 Vaccine

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

AIDS Res Hum Retroviruses

1. KALLIANPUR KJ, Walker M, Gerschenson M, Shikuma C, et al
   Systemic Mitochondrial Oxidative Phosphorylation Protein Levels Correlate with Neuroimaging Measures in Chronically HIV-Infected Individuals.
   AIDS Res Hum Retroviruses. 2019 Oct 16. doi: 10.1089/AID.2019.0240.
   PubMed     Text format     Abstract available
   
   
2. TORRES MKS, Avelino MES, Irias SDF, Santos MB, et al
   Low prevalence of HIV-1 integrase resistance among antiretroviral-naive patients newly diagnosed with HIV-1 from Belem, Para, Amazon Region of Brazil.
   AIDS Res Hum Retroviruses. 2019 Oct 14. doi: 10.1089/AID.2019.0191.
   PubMed     Text format     Abstract available
   
   
3. DUBE K, Eskaf S, Evans D, Sauceda J, et al
   The Dose Response: Perceptions of People Living with HIV in the United States on Alternatives to Oral Daily Antiretroviral Therapy.
   AIDS Res Hum Retroviruses. 2019 Oct 14. doi: 10.1089/AID.2019.0175.
   PubMed     Text format     Abstract available
   
   
4. LAU J, Smith MZ, Allan B, Martinez C, et al
   Community and provider Community and provider perspectives on Treatment Interruptions in the landscape of HIV cure focused studies.
   AIDS Res Hum Retroviruses. 2019 Oct 14. doi: 10.1089/AID.2019.0118.
   PubMed     Text format     Abstract available
   
   

   
   Am J Epidemiol

5. WANG L, Moqueet N, Lambert G, Grace D, et al
   Population-Level Sexual Mixing By HIV Status and Pre-exposure Prophylaxis Use Among Men Who Have Sex with Men in Montreal, Canada: Implications for HIV Prevention.
   Am J Epidemiol. 2019 Oct 15. pii: 5587085. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
6. ALTHOFF KN, Chandran A, Zhang J, Arevalo WM, et al
   LIFE EXPECTANCY DISPARITIES AMONG ADULTS WITH HIV IN THE UNITED STATES AND CANADA: THE IMPACT OF A REDUCTION IN DRUG- AND ALCOHOL-RELATED DEATHS USING THE LIVES SAVED SIMULATION (LISSO) MODEL.
   Am J Epidemiol. 2019 Oct 11. pii: 5583226. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
7. MACINSKI SE, Gunn JKL, Goyal M, Neighbors C, et al
   Validation of an Optimized Algorithm to Identify Persons Living with Diagnosed HIV from the New York State Medicaid Data, 2006-2014.
   Am J Epidemiol. 2019 Oct 15. pii: 5587083. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   Ann Intern Med

8. SINGH M
   Guideline: USPSTF recommends preexposure prophylaxis with antiretroviral therapy for persons at high risk for HIV.
   Ann Intern Med. 2019;171:JC38.
   PubMed     Text format    
   
   

   
   Antimicrob Agents Chemother

9. SALADINI F, Giannini A, Boccuto A, Dragoni F, et al
   Comparable in vitro activity of second-generation HIV-1 integrase strand transfer inhibitors (INSTIs) on HIV-1 clinical isolates with INSTI resistance mutations.
   Antimicrob Agents Chemother. 2019 Oct 14. pii: AAC.01717.
   PubMed     Text format     Abstract available
   
   
10. FISCHER K, Nguyen K, LiWang PJ
    Griffithsin retains anti-HIV-1 potency with changes in gp120 glycosylation and complements broadly neutralizing antibodies PGT121 and PGT126.
    Antimicrob Agents Chemother. 2019 Oct 14. pii: AAC.01084.
    PubMed     Text format     Abstract available
    
    
11. DEVANATHAN AS, Pirone JR, Akkina R, Remling-Mulder L, et al
    Antiretroviral penetration across three preclinical animal models and humans in eight putative HIV viral reservoirs.
    Antimicrob Agents Chemother. 2019 Oct 14. pii: AAC.01639.
    PubMed     Text format     Abstract available
    
    

    
    BMC Immunol

12. DESALEGN G, Tsegaye A, Gebreegziabiher D, Aseffa A, et al
    Enhanced IFN-gamma, but not IL-2, response to Mycobacterium tuberculosis antigens in HIV/latent TB co-infected patients on long-term HAART.
    BMC Immunol. 2019;20:35.
    PubMed     Text format     Abstract available
    
    

    
    Br J Haematol

13. NYLAND SB, Feith DJ, Poss M, Olson TL, et al
    Retroviral sero-reactivity in LGL leukaemia patients and family members.
    Br J Haematol. 2019 Oct 14. doi: 10.1111/bjh.16223.
    PubMed     Text format     Abstract available
    
    

    
    Clin Infect Dis

14. LE GUILLOU A, Pugliese P, Raffi F, Cabie A, et al
    Reaching the Second and Third Joint United Nations Programme on HIV/AIDS 90-90-90 Targets Is Accompanied by a Dramatic Reduction in Primary Human Immunodeficiency Virus (HIV) Infection and in Recent HIV Infections in a Large French Nationwide HIV Coho
    Clin Infect Dis. 2019 Aug 17. pii: 5550908. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
15. SAX PE, Erlandson KM, Lake JE, McComsey GA, et al
    Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials.
    Clin Infect Dis. 2019 Oct 14. pii: 5586728. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
16. LEDDY AM, Sheira LA, Tamraz B, Sykes C, et al
    Food insecurity is associated with lower levels of antiretroviral drug concentrations in hair among a cohort of women living with HIV in the United States.
    Clin Infect Dis. 2019 Oct 14. pii: 5586763. doi: 10.1093/cid/ciz1007.
    PubMed     Text format     Abstract available
    
    
17. SHIN SS, Satyanarayana VA, Ekstrand ML, Carpenter CL, et al
    The effect of community-based nutritional interventions on children of women living with HIV in rural India: A 2 x 2 factorial intervention trial.
    Clin Infect Dis. 2019 Oct 14. pii: 5586765. doi: 10.1093/cid/ciz1009.
    PubMed     Text format     Abstract available
    
    
18. BURNHAM JP, Geng E, Venkatram C, Colditz GA, et al
    Putting the Dissemination and Implementation in Infectious Diseases.
    Clin Infect Dis. 2019 Oct 14. pii: 5586766. doi: 10.1093/cid/ciz1011.
    PubMed     Text format     Abstract available
    
    
19. OFOTOKUN I, Collins LF, Titanji K, Foster A, et al
    Antiretroviral Therapy-induced Bone Loss is Durably Suppressed by a Single Dose of Zoledronic Acid in Treatment-naive Persons with HIV Infection: a Phase IIB Trial.
    Clin Infect Dis. 2019 Oct 17. pii: 5588958. doi: 10.1093/cid/ciz1027.
    PubMed     Text format     Abstract available
    
    
20. RAMENDRA R, Isnard S, Lin J, Fombuena B, et al
    CMV seropositivity is associated with increased microbial translocation in people living with HIV and uninfected controls.
    Clin Infect Dis. 2019 Oct 14. pii: 5586739. doi: 10.1093/cid/ciz1001.
    PubMed     Text format     Abstract available
    
    
21. FOJO AT, Dowdy DW
    Ending the HIV Epidemic: Towards an Evidence-Based Approach.
    Clin Infect Dis. 2019 Oct 14. pii: 5586985. doi: 10.1093/cid/ciz1018.
    PubMed     Text format    
    
    
22. NOSYK B, Zang X, Krebs E, Min JE, et al
    Ending the epidemic in America will not happen if the status quo continues: modeled projections for HIV incidence in 6 US cities.
    Clin Infect Dis. 2019 Oct 14. pii: 5587001. doi: 10.1093/cid/ciz1015.
    PubMed     Text format     Abstract available
    
    
23. CHOW DC, Bernas MA, Gangcuangco LM, Huynh J, et al
    Frailty is associated with insulin resistance in chronic HIV.
    Clin Infect Dis. 2019 Oct 15. pii: 5587091. doi: 10.1093/cid/ciz1017.
    PubMed     Text format    
    
    
24. NEWMAN KL, Newman GS, Cybulski RJ, Fang FC, et al
    Gastroenteritis in Men Who Have Sex With Men in Seattle, Washington, 2017-2018.
    Clin Infect Dis. 2019 Oct 17. pii: 5588835. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
25. NAIDOO K, Hassan-Moosa R, Mlotshwa P, Yende-Zuma N, et al
    High Rates of Drug-induced Liver Injury in People Living With HIV Coinfected With Tuberculosis (TB) Irrespective of Antiretroviral Therapy Timing During Antituberculosis Treatment: Results From the Starting Antiretroviral Therapy at Three Points in TB
    Clin Infect Dis. 2019 Oct 17. pii: 5589114. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    HIV Med

26. ORBAEK M, Thorsteinsson K, Moseholm Larsen E, Katzenstein TL, et al
    Risk factors during pregnancy and birth-related complications in HIV-positive versus HIV-negative women in Denmark, 2002-2014.
    HIV Med. 2019 Oct 11. doi: 10.1111/hiv.12798.
    PubMed     Text format     Abstract available
    
    
27. RIPAMONTI E, Clerici M
    The association of memory disorders and chronic HIV disease in the antiretroviral therapy era: a systematic literature review.
    HIV Med. 2019 Oct 11. doi: 10.1111/hiv.12793.
    PubMed     Text format     Abstract available
    
    
28. SERRAO A, Santoro C, Foa R, Chistolini A, et al
    Use of edoxaban for the treatment of venous thromboembolism in HIV-infected patients.
    HIV Med. 2019 Oct 16. doi: 10.1111/hiv.12803.
    PubMed     Text format    
    
    
29. FRANCIS-MORRIS A, Mackie NE, Eliahoo J, Ramzan F, et al
    Compromised CD4:CD8 ratio recovery in people living with HIV aged over 50 years: an observational study.
    HIV Med. 2019 Oct 16. doi: 10.1111/hiv.12800.
    PubMed     Text format     Abstract available
    
    
30. INCIARTE A, Leal L, Masfarre L, Gonzalez E, et al
    Post-exposure prophylaxis for HIV infection in sexual assault victims.
    HIV Med. 2019 Oct 11. doi: 10.1111/hiv.12797.
    PubMed     Text format     Abstract available
    
    
31. WILKINSON A, Quinn B, Draper B, White S, et al
    Prevalence of daily tobacco smoking participation among HIV-positive and HIV-negative Australian gay, bisexual and other men who have sex with men.
    HIV Med. 2019 Oct 11. doi: 10.1111/hiv.12802.
    PubMed     Text format    
    
    

    
    Int J Cancer

32. SHMAKOVA A, Germini D, Vassetzky Y
    HIV-1, HAART and cancer: a complex relationship.
    Int J Cancer. 2019 Oct 11. doi: 10.1002/ijc.32730.
    PubMed     Text format     Abstract available
    
    

    
    J Acquir Immune Defic Syndr

33. SALVATORE P, Johnson K, Vojnov L, Doherty M, et al
    Clinical Consequences of Using an Indeterminate Range for Early Infant Diagnosis of HIV: A Decision Model.
    J Acquir Immune Defic Syndr. 2019;82:287-296.
    PubMed     Text format     Abstract available
    
    
34. LUO R, Boeras D, Broyles LN, Fong Y, et al
    Use of an Indeterminate Range in HIV Early Infant Diagnosis: A Systematic Review and Meta-Analysis.
    J Acquir Immune Defic Syndr. 2019;82:281-286.
    PubMed     Text format     Abstract available
    
    
35. DIRAJLAL-FARGO S, Yu J, Kulkarni M, Sattar A, et al
    Brief Report: Zinc Supplementation and Inflammation in Treated HIV.
    J Acquir Immune Defic Syndr. 2019;82:275-280.
    PubMed     Text format     Abstract available
    
    
36. LODI S, Gunthard HF, Gill J, Phillips AN, et al
    Effectiveness of Transmitted Drug Resistance Testing Before Initiation of Antiretroviral Therapy in HIV-Positive Individuals.
    J Acquir Immune Defic Syndr. 2019;82:314-320.
    PubMed     Text format     Abstract available
    
    
37. KITYO C, Hagins D, Koenig E, Avihingsanon A, et al
    Switching to Fixed-Dose Bictegravir, Emtricitabine, and Tenofovir Alafenamide (B/F/TAF) in Virologically Suppressed HIV-1 Infected Women: A Randomized, Open-Label, Multicenter, Active-Controlled, Phase 3, Noninferiority Trial.
    J Acquir Immune Defic Syndr. 2019;82:321-328.
    PubMed     Text format     Abstract available
    
    
38. GILBERT HN, Wyatt MA, Pisarski EE, Muwonge TR, et al
    PrEP Discontinuation and Prevention-Effective Adherence: Experiences of PrEP Users in Ugandan HIV Serodiscordant Couples.
    J Acquir Immune Defic Syndr. 2019;82:265-274.
    PubMed     Text format     Abstract available
    
    

    
    J Infect Dis

39. CHIHOTA BV, Wandeler G, Chilengi R, Mulenga L, et al
    High Rates of Hepatitis B Virus (HBV) Functional Cure Among Human Immunodeficiency Virus-HBV Coinfected Patients on Antiretroviral Therapy in Zambia.
    J Infect Dis. 2019 Oct 15. pii: 5581876. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
40. WOOD MP, Wood LF, Templeton M, Fisher B, et al
    Transient Immune Activation in BCG-Vaccinated Infant Rhesus Macaques Is Not Sufficient to Influence Oral Simian Immunodeficiency Virus Infection.
    J Infect Dis. 2019 Oct 12. pii: 5586557. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
41. KILAPANDAL VENKATRAMAN SM, Sivanandham R, Pandrea I, Apetrei C, et al
    BCG Vaccination and Mother-to-Infant Transmission of HIV.
    J Infect Dis. 2019 Oct 12. pii: 5586559. doi: 10.1093.
    PubMed     Text format    
    
    

    
    J Med Virol

42. REN L, Wang B, Miao Z, Liu P, et al
    A Correlation Analysis of HHV Infection and Its Predictive Factors in An HIV-seropositive Population in Yunnan, China.
    J Med Virol. 2019 Oct 17. doi: 10.1002/jmv.25609.
    PubMed     Text format     Abstract available
    
    

    
    J Virol

43. VAN DORSTEN RT, Lambson BE, Wibmer CK, Weinberg MS, et al
    Neutralization breadth and potency of single-chain variable fragments derived from broadly neutralizing antibodies targeting multiple epitopes on the HIV-1 envelope.
    J Virol. 2019 Oct 16. pii: JVI.01533-19. doi: 10.1128/JVI.01533.
    PubMed     Text format     Abstract available
    
    
44. RINGE RP, Colin P, Torres JL, Yasmeen A, et al
    SOS and IP modifications predominantly affect the yield but not other properties of SOSIP.664 HIV-1 Env glycoprotein trimers.
    J Virol. 2019 Oct 16. pii: JVI.01521-19. doi: 10.1128/JVI.01521.
    PubMed     Text format     Abstract available
    
    
45. ZHU Y, Ding X, Yu D, Chong H, et al
    The Tryptophan-Rich Motif of HIV-1 Gp41 Can Interact with the N-Terminal Deep Pocket Site: New Insights into the Structure and Function of Gp41 and Its Inhibitors.
    J Virol. 2019 Oct 16. pii: JVI.01358-19. doi: 10.1128/JVI.01358.
    PubMed     Text format     Abstract available
    
    
46. MAVIGNER M, Zanoni M, Tharp GK, Habib J, et al
    Pharmacological modulation of the Wnt/beta-catenin pathway inhibits proliferation and promotes differentiation of long-lived memory CD4(+) T-cells in ART-suppressed SIV-infected macaques.
    J Virol. 2019 Oct 16. pii: JVI.01094-19. doi: 10.1128/JVI.01094.
    PubMed     Text format     Abstract available
    
    
47. KIBLER KV, Asbach B, Perdiguero B, Garcia-Arriaza J, et al
    Correction for Kibler et al., "Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC".
    J Virol. 2019;93.
    PubMed     Text format    
    
    
48. TEDBURY PR, Novikova M, Alfadhli A, Hikichi Y, et al
    HIV-1 matrix trimerization-impaired mutants are rescued by matrix substitutions that enhance envelope glycoprotein incorporation.
    J Virol. 2019 Oct 16. pii: JVI.01526-19. doi: 10.1128/JVI.01526.
    PubMed     Text format     Abstract available
    
    

    
    Lancet Glob Health

49. BIRDTHISTLE I, Tanton C, Tomita A, de Graaf K, et al
    Recent levels and trends in HIV incidence rates among adolescent girls and young women in ten high-prevalence African countries: a systematic review and meta-analysis.
    Lancet Glob Health. 2019;7:e1521-e1540.
    PubMed     Text format     Abstract available
    
    
50. KARIM SSA, Baxter C
    HIV incidence rates in adolescent girls and young women in sub-Saharan Africa.
    Lancet Glob Health. 2019;7:e1470-e1471.
    PubMed     Text format    
    
    

    
    Lancet HIV

51. STANNAH J, Dale E, Elmes J, Staunton R, et al
    HIV testing and engagement with the HIV treatment cascade among men who have sex with men in Africa: a systematic review and meta-analysis.
    Lancet HIV. 2019 Oct 7. pii: S2352-3018(19)30239.
    PubMed     Text format     Abstract available
    
    
52. AUDSLEY J, Sasadeusz J, Lewin SR
    Tesamorelin, liver fat, and NAFLD in the setting of HIV.
    Lancet HIV. 2019 Oct 11. pii: S2352-3018(19)30331.
    PubMed     Text format    
    
    
53. BIGNA JJ, Nansseu JR
    Men who have sex with men: a key population in Africa.
    Lancet HIV. 2019 Oct 7. pii: S2352-3018(19)30265.
    PubMed     Text format    
    
    
54. COHEN K, Orrell CJ
    Transition to third-line ART in resource-limited settings.
    Lancet HIV. 2019 Oct 7. pii: S2352-3018(19)30324.
    PubMed     Text format    
    
    
55. EHOLIE SP, Moh R, Benalycherif A, Gabillard D, et al
    Implementation of an intensive adherence intervention in patients with second-line antiretroviral therapy failure in four west African countries with little access to genotypic resistance testing: a prospective cohort study.
    Lancet HIV. 2019 Oct 7. pii: S2352-3018(19)30228.
    PubMed     Text format     Abstract available
    
    
56. FELBER BK, Pavlakis GN
    HIV vaccine: better to start together?
    Lancet HIV. 2019 Oct 7. pii: S2352-3018(19)30323.
    PubMed     Text format    
    
    
57. PANTALEO G, Janes H, Karuna S, Grant S, et al
    Safety and immunogenicity of a multivalent HIV vaccine comprising envelope protein with either DNA or NYVAC vectors (HVTN 096): a phase 1b, double-blind, placebo-controlled trial.
    Lancet HIV. 2019 Oct 7. pii: S2352-3018(19)30262.
    PubMed     Text format     Abstract available
    
    
58. STANLEY TL, Fourman LT, Feldpausch MN, Purdy J, et al
    Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial.
    Lancet HIV. 2019 Oct 11. pii: S2352-3018(19)30338.
    PubMed     Text format     Abstract available
    
    

    
    Lancet Respir Med

59. CYPEL M, Feld JJ, Galasso M, Pinto Ribeiro RV, et al
    Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trial.
    Lancet Respir Med. 2019 Oct 9. pii: S2213-2600(19)30268.
    PubMed     Text format     Abstract available
    
    

    
    Nature

60. BURSTEIN R, Henry NJ, Collison ML, Marczak LB, et al
    Mapping 123 million neonatal, infant and child deaths between 2000 and 2017.
    Nature. 2019;574:353-358.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

61. TARAMASSO L, Di Biagio A, Riccardi N, Briano F, et al
    Lipid profile changings after switching from rilpivirine/tenofovir disoproxil fumarate/emtricitabine to rilpivirine/tenofovir alafenamide/emtricitabine: Different effects in patients with or without baseline hypercholesterolemia.
    PLoS One. 2019;14:e0223181.
    PubMed     Text format     Abstract available
    
    
62. SIMEON K, Sharma M, Dorward J, Naidoo J, et al
    Comparative cost analysis of point-of-care versus laboratory-based testing to initiate and monitor HIV treatment in South Africa.
    PLoS One. 2019;14:e0223669.
    PubMed     Text format     Abstract available
    
    
63. MALELE KOLISA Y, Yengopal V, Shumba K, Igumbor J, et al
    The burden of oral conditions among adolescents living with HIV at a clinic in Johannesburg, South Africa.
    PLoS One. 2019;14:e0222568.
    PubMed     Text format     Abstract available
    
    
64. BRODY C, Chhoun P, Tuot S, Swendeman D, et al
    Childhood conditions, pathways to entertainment work and current practices of female entertainment workers in Cambodia: Baseline findings from the Mobile Link trial.
    PLoS One. 2019;14:e0216578.
    PubMed     Text format     Abstract available
    
    
65. IGUMBOR JO, Ouma J, Otwombe K, Musenge E, et al
    Effect of a Mentor Mother Programme on retention of mother-baby pairs in HIV care: A secondary analysis of programme data in Uganda.
    PLoS One. 2019;14:e0223332.
    PubMed     Text format     Abstract available
    
    
66. DI CRISTANZIANO V, D Alfonso R, Berrilli F, Sarfo FS, et al
    Correction: Lower prevalence of Blastocystis sp. infections in HIV positive compared to HIV negative adults in Ghana.
    PLoS One. 2019;14:e0224000.
    PubMed     Text format     Abstract available
    
    
67. 
    Correction: Factors associated with hospitalization and death among TB/HIV co-infected persons in Porto Alegre, Brazil.
    PLoS One. 2019;14:e0224230.
    PubMed     Text format     Abstract available
    
    
68. FOCA E, Magro P, Guaraldi G, Riva A, et al
    Elderly HIV-positive women: A gender-based analysis from the Multicenter Italian "GEPPO" Cohort.
    PLoS One. 2019;14:e0222225.
    PubMed     Text format     Abstract available
    
    
69. FANJUL F, Campins A, Asensio J, Samperiz G, et al
    Interatrial blocks prevalence and risk factors for human immunodeficiency virus-infected persons.
    PLoS One. 2019;14:e0223777.
    PubMed     Text format     Abstract available
    
    
70. JERENE D, Abebe W, Taye K, Ruff A, et al
    Adolescents living with HIV are at higher risk of death and loss to follow up from care: Analysis of cohort data from eight health facilities in Ethiopia.
    PLoS One. 2019;14:e0223655.
    PubMed     Text format     Abstract available
    
    
71. SIKOMBE K, Hantuba C, Musukuma K, Sharma A, et al
    Accurate dried blood spots collection in the community using non-medically trained personnel could support scaling up routine viral load testing in resource limited settings.
    PLoS One. 2019;14:e0223573.
    PubMed     Text format     Abstract available
    
    
72. VOJTECH L, Zhang M, Dave V, Levy C, et al
    Extracellular vesicles in human semen modulate antigen-presenting cell function and decrease downstream antiviral T cell responses.
    PLoS One. 2019;14:e0223901.
    PubMed     Text format     Abstract available
    
    
73. DICKER I, Zhang S, Ray N, Beno BR, et al
    Resistance profile of the HIV-1 maturation inhibitor GSK3532795 in vitro and in a clinical study.
    PLoS One. 2019;14:e0224076.
    PubMed     Text format     Abstract available
    
    

    
    PLoS Pathog

74. WONDERLICH ER, Subramanian K, Cox B, Wiegand A, et al
    Effector memory differentiation increases detection of replication-competent HIV-l in resting CD4+ T cells from virally suppressed individuals.
    PLoS Pathog. 2019;15:e1008074.
    PubMed     Text format     Abstract available
    
    

    
    Vaccine

75. BERNSTEIN DI, Morello CS, Cardin RD, Bravo FJ, et al
    A vaccine containing highly purified virus particles in adjuvant provides high level protection against genital infection and disease in guinea pigs challenged intravaginally with homologous and heterologous strains of herpes simplex virus type 2.
    Vaccine. 2019 Oct 11. pii: S0264-410X(19)31332.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: